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eower Vitamin D Status May
xplain the Higher Prevalence
f Peripheral Arterial Disease
mong African Americans
he report that the etiology of dramatically higher prevalence of
eripheral arterial disease (PAD) among African Americans
annot be explained by traditional or novel cardiovascular
isease risk markers (1) suggests that other factors are involved.
factor overlooked in the study by Ix et al. (1) that may explain
he higher prevalence is lower vitamin D status for African
mericans. Hypovitaminosis D is present in a substantial
roportion of the African-American population due to dark
kin, low oral intake of vitamin D, and possibly higher body fat
evels (2,3).
Observational evidence linking low serum 25-hydroxyvitamin D
o increased risk of PAD was recently reported based on data from
,839 participants of the National Health and Nutrition Exami-
ation Survey 2001 to 2004. For each 10 ng/ml lower 25 (OH)
itamin D level, the multivariable-adjusted prevalence ratio of
AD was 1.35 (95% confidence interval: 1.15 to 1.59) (4).
In addition, there is indirect evidence of a link. Diabetes
ellitus is a risk factor for PAD (1), and those with diabetes
ellitus have an increased risk of PAD (5). Those with PAD
ften have osteoporosis (6). Cardiovascular disease, another risk
actor for PAD (1), has now been linked to low vitamin D as
ell (7).
Further testing of this hypothesis could be done via random-
zed controlled trials, perhaps based on a post hoc analysis of an
xisting trial, for example (8). If the hypothesis is correct,
ncreasing serum calcidiol levels for those at risk of PAD would
educe the risk and severity of PAD, and have many other
ealth benefits as well (9). Additional support for a role of
itamin D in reducing the risk of PAD appeared recently (10).
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eply
t is possible that vitamin D status could represent an unmeasured
onfounder explaining the higher prevalence of peripheral arterial
isease (PAD) among African Americans (1). Vitamin D levels
ere not available in our study, so we cannot directly confirm or
efute this hypothesis. However, to explain the residual 1.9-fold
igher odds of PAD among African Americans compared with
hat in Caucasians, any unmeasured confounder would need to be
trongly associated with both African-American race and PAD.
rior studies have demonstrated that African Americans have
ower serum 25 (OH) vitamin D levels (2,3). Until recently, the
ssociation of vitamin D with PAD was unknown.
Published the same month as our study, Melamed et al. (4)
eported that lower vitamin D levels were independently associated
ith PAD among 4,839 National Health and Nutrition Exami-
ation Survey participants (approximately 500 were African Amer-
can). While the authors did not directly evaluate whether the
ssociation of African-American race with PAD was attenuated
ith statistical adjustment for vitamin D, they did report subgroup
nalysis stratified by race. Here, they report that each 10 ng/ml
ower vitamin D was associated with an odds ratio of 1.11 (95%
onfidence interval: 0.81 to 1.53) for PAD among African Amer-
cans, while the same comparison provided an odds ratio of 1.39 (95%
onfidence interval: 1.16 to 1.66) among Caucasians. Thus, the
ssociation was weaker in African Americans. This suggests, but
oes not prove, that vitamin D is unlikely to account for the higher
revalence of PAD among African Americans in isolation. How-
ver, the p values for interaction by race were not statistically
ignificant in this study, so the weaker association in African
